UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Magnetic resonance imaging characteristics in patients with spondyloarthritis and clinical diagnosis of heel enthesitis: post hoc analysis from the phase 3 ACHILLES trial

Arthritis research & therapy, 2022-05, Vol.24 (1), p.111-111, Article 111

2022

Volltextzugriff (PDF)

Secukinumab dosing optimization in patients with moderate‐to‐severe plaque psoriasis: results from the randomized, open‐label OPTIMISE study

British journal of dermatology (1951), 2020-02, Vol.182 (2), p.304-315

2020

Volltextzugriff (PDF)

PO2-25: Assessment of hydration based on bioelectrical impedance analysis (BIA) and arm muscle area (AMA) in treatment-naïve adult patients with growth hormone deficiency (GHD)

Growth hormone & IGF research, 2014-10, Vol.24, p.S47-S47

2014

Volltextzugriff (PDF)

GP3-1: Growth hormone (GH) replacement has a beneficial effect on glycosylated haemoglobin (HbA1c) levels in adult patients with GH deficiency (GHD) enrolled in the NordiNet® International Outcome Study (IOS)

Growth hormone & IGF research, 2014-10, Vol.24, p.S37-S37

2014

Volltextzugriff (PDF)

PO2-20: Safety evaluation of long-term recombinant growth hormone (rGH) treatment in paediatric patients: interim analysis of NordiNet® International Outcome Study (IOS)

Growth hormone & IGF research, 2014-10, Vol.24, p.S45-S45

2014

Volltextzugriff (PDF)

Mechanical Behavior of Dented Steel Pipes Subjected to Bending and Pressure Loading

Journal of offshore mechanics and Arctic engineering, 2019-02, Vol.141 (1)

2019

Volltextzugriff (PDF)

POS1110 PATIENT CLUSTERS IDENTIFIED BY MACHINE LEARNING: DATA FROM A POOLED ANALYSIS OF PHASE-3 TRIALS OF SECUKINUMAB IN PSORIATIC ARTHRITIS, ANKYLOSING SPONDYLITIS AND PSORIATIC ARTHRITIS WITH AXIAL MANIFESTATIONS

Annals of the rheumatic diseases, 2023-06, Vol.82 (Suppl 1), p.879-879

2023

Volltextzugriff (PDF)

CFRP Reinforcement and Repair of Steel Pipe Elbows Subjected to Severe Cyclic Loading

Journal of pressure vessel technology, 2017-10, Vol.139 (5)

2017

Volltextzugriff (PDF)

Is safety of childhood growth hormone therapy related to dose? Data from a large observational study

European journal of endocrinology, 2016-05, Vol.174 (5), p.681-691

2016

Volltextzugriff (PDF)

Patient clusters identified by machine learning from a pooled analysis of the clinical development programme of secukinumab in psoriatic arthritis, ankylosing spondylitis and psoriatic arthritis with axial manifestations

Clinical and experimental rheumatology, 2024-03

2024

Volltextzugriff (PDF)

POS1053 LONG-TERM RETENTION, EFFECTIVENESS AND SAFETY OF SECUKINUMAB IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS OR ANKYLOSING SPONDYLITIS: RESULTS FROM THE OBSERVATIONAL SERENA STUDY

Annals of the rheumatic diseases, 2022-06, Vol.81 (Suppl 1), p.846-847

2022

Volltextzugriff (PDF)

The effect of growth hormone (GH) replacement on blood glucose homeostasis in adult nondiabetic patients with GH deficiency: real‐life data from the NordiNet® International Outcome Study

Clinical endocrinology (Oxford), 2017-02, Vol.86 (2), p.192-198

2017

Volltextzugriff (PDF)

POS0930 SECUKINUMAB IN PATIENTS WITH PSORIATIC ARTHRITIS AND AXIAL MANIFESTATIONS: PREDICTORS OF RESPONSE FROM THE DOUBLE-BLIND, RANDOMISED, PHASE 3B MAXIMISE TRIAL

Annals of the rheumatic diseases, 2021-06, Vol.80 (Suppl 1), p.728-728

2021

Volltextzugriff (PDF)

POS0234 SECUKINUMAB RETENTION AND SAFETY IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS OR ANKYLOSING SPONDYLITIS: 2 YEAR INTERIM RESULTS OF THE OBSERVATIONAL SERENA STUDY

Annals of the rheumatic diseases, 2021-06, Vol.80 (Suppl 1), p.337-338

2021

Volltextzugriff (PDF)

AB0659 SECUKINUMAB PROVIDES SIGNIFICANT IMPROVEMENT OF SPINAL PAIN IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS: RESULTS FROM THE 24-WEEK PHASE 3 SKIPPAIN STUDY

Annals of the rheumatic diseases, 2020-06, Vol.79 (Suppl 1), p.1624-1625

2020

Volltextzugriff (PDF)

OP0053 SECUKINUMAB IMPROVES CLINICAL AND IMAGING OUTCOMES IN PATIENTS WITH PSORIATIC ARTHRITIS AND AXIAL MANIFESTATIONS WITH INADEQUATE RESPONSE TO NSAIDS: WEEK 52 RESULTS FROM THE MAXIMISE TRIAL

Annals of the rheumatic diseases, 2020-06, Vol.79 (Suppl 1), p.35-36

2020

Volltextzugriff (PDF)

Differences in human papillomavirus type distribution in high‐grade cervical intraepithelial neoplasia and invasive cervical cancer in Europe

International journal of cancer, 2013-02, Vol.132 (4), p.854-867

2013

Volltextzugriff (PDF)

Is safety of childhood growth hormone therapy related to dose? Data from a large observational study

European journal of endocrinology, 2017-03, Vol.176 (3), p.X1

2017

Volltextzugriff (PDF)

Facteurs prédictifs de réponse au sécukinumab chez les patients atteints de rhumatisme psoriasique avec manifestation axiale : analyse post-hoc de l’essai randomisé contrôlé MAXIMISE

Revue du rhumatisme (Ed. française : 1993), 2021-12, Vol.88, p.A225

2021

Volltextzugriff (PDF)

Facteurs prédictifs de réponse au sécukinumab chez les patients atteints de spondylarthrite ankylosante : analyse par régression logistique et machine learning

Revue du rhumatisme (Ed. française : 1993), 2020-12, Vol.87, p.A28-A28

2020

Volltextzugriff (PDF)

Is GH dosing optimal in female patients with adult‐onset GH deficiency? An analysis from the NordiNet® International Outcome Study

Clinical endocrinology (Oxford), 2017-06, Vol.86 (6), p.798-805

2017

Volltextzugriff (PDF)

Structural resistance of high-strength steel CHS members

Journal of constructional steel research, 2017-01, Vol.128, p.152-165

2017

Volltextzugriff (PDF)

Tolérance et maintien sous traitement par sécukinumab chez des patients atteints de rhumatisme psoriasique ou de spondyloarthrite ankylosante : résultats intermédiaires à 2 ans de l’étude observationnelle SERENA

Revue du rhumatisme (Ed. française : 1993), 2021-12, Vol.88, p.A55-A56

2021

Volltextzugriff (PDF)

Efficacité du sécukinumab chez les patients atteints de rhumatisme psoriasique avec manifestations axiales : efficacité clinique et IRM à 52 semaines dans l’essai randomisé contrôlé MAXIMISE

Revue du rhumatisme (Ed. française : 1993), 2020-12, Vol.87, p.A174-A174

2020

Volltextzugriff (PDF)

Towards a Framework for Adapting Machine Learning Components

2022 IEEE International Conference on Autonomic Computing and Self-Organizing Systems (ACSOS), 2022, p.131-140

2022

Volltextzugriff (PDF)

1 – 25 von 104

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(52)
Mit Volltextzugriff
(44)

Publikationsform

Sprache

Englisch
(99)
Französisch
(4)

Erscheinungsjahr

n.n

Thema

Science & Technology
(78)
Technology
(50)
Engineering
(48)
Computer Science
(45)
Computer Science, Information Systems
(45)
Computer Science, Theory & Methods
(45)
Engineering, Electrical & Electronic
(45)
Self Organizing Systems
(45)
Life Sciences & Biomedicine
(26)
Humans
(24)
Adaptive Systems
(19)
Distributed Computing
(17)
Female
(15)
Computational Modeling
(13)
Male
(13)
Algorithms
(11)
Adaptation Models
(10)
Machine Learning
(10)
Medicin Och Hälsovetenskap
(10)
Middle Aged
(10)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Magnetic resonance imaging characteristics in patients with spondyloarthritis and clinical diagnosis of heel enthesitis: post hoc analysis from the phase 3 ACHILLES trial

Secukinumab dosing optimization in patients with moderate‐to‐severe plaque psoriasis: results from the randomized, open‐label OPTIMISE study

PO2-25: Assessment of hydration based on bioelectrical impedance analysis (BIA) and arm muscle area (AMA) in treatment-naïve adult patients with growth hormone deficiency (GHD)

GP3-1: Growth hormone (GH) replacement has a beneficial effect on glycosylated haemoglobin (HbA1c) levels in adult patients with GH deficiency (GHD) enrolled in the NordiNet® International Outcome Study (IOS)

PO2-20: Safety evaluation of long-term recombinant growth hormone (rGH) treatment in paediatric patients: interim analysis of NordiNet® International Outcome Study (IOS)

Mechanical Behavior of Dented Steel Pipes Subjected to Bending and Pressure Loading

POS1110 PATIENT CLUSTERS IDENTIFIED BY MACHINE LEARNING: DATA FROM A POOLED ANALYSIS OF PHASE-3 TRIALS OF SECUKINUMAB IN PSORIATIC ARTHRITIS, ANKYLOSING SPONDYLITIS AND PSORIATIC ARTHRITIS WITH AXIAL MANIFESTATIONS

CFRP Reinforcement and Repair of Steel Pipe Elbows Subjected to Severe Cyclic Loading

Is safety of childhood growth hormone therapy related to dose? Data from a large observational study

Patient clusters identified by machine learning from a pooled analysis of the clinical development programme of secukinumab in psoriatic arthritis, ankylosing spondylitis and psoriatic arthritis with axial manifestations

POS1053 LONG-TERM RETENTION, EFFECTIVENESS AND SAFETY OF SECUKINUMAB IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS OR ANKYLOSING SPONDYLITIS: RESULTS FROM THE OBSERVATIONAL SERENA STUDY

The effect of growth hormone (GH) replacement on blood glucose homeostasis in adult nondiabetic patients with GH deficiency: real‐life data from the NordiNet® International Outcome Study

POS0930 SECUKINUMAB IN PATIENTS WITH PSORIATIC ARTHRITIS AND AXIAL MANIFESTATIONS: PREDICTORS OF RESPONSE FROM THE DOUBLE-BLIND, RANDOMISED, PHASE 3B MAXIMISE TRIAL

POS0234 SECUKINUMAB RETENTION AND SAFETY IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS OR ANKYLOSING SPONDYLITIS: 2 YEAR INTERIM RESULTS OF THE OBSERVATIONAL SERENA STUDY

AB0659 SECUKINUMAB PROVIDES SIGNIFICANT IMPROVEMENT OF SPINAL PAIN IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS: RESULTS FROM THE 24-WEEK PHASE 3 SKIPPAIN STUDY

OP0053 SECUKINUMAB IMPROVES CLINICAL AND IMAGING OUTCOMES IN PATIENTS WITH PSORIATIC ARTHRITIS AND AXIAL MANIFESTATIONS WITH INADEQUATE RESPONSE TO NSAIDS: WEEK 52 RESULTS FROM THE MAXIMISE TRIAL

Differences in human papillomavirus type distribution in high‐grade cervical intraepithelial neoplasia and invasive cervical cancer in Europe

Is safety of childhood growth hormone therapy related to dose? Data from a large observational study

Facteurs prédictifs de réponse au sécukinumab chez les patients atteints de rhumatisme psoriasique avec manifestation axiale : analyse post-hoc de l’essai randomisé contrôlé MAXIMISE

Facteurs prédictifs de réponse au sécukinumab chez les patients atteints de spondylarthrite ankylosante : analyse par régression logistique et machine learning

Is GH dosing optimal in female patients with adult‐onset GH deficiency? An analysis from the NordiNet® International Outcome Study

Structural resistance of high-strength steel CHS members

Tolérance et maintien sous traitement par sécukinumab chez des patients atteints de rhumatisme psoriasique ou de spondyloarthrite ankylosante : résultats intermédiaires à 2 ans de l’étude observationnelle SERENA

Efficacité du sécukinumab chez les patients atteints de rhumatisme psoriasique avec manifestations axiales : efficacité clinique et IRM à 52 semaines dans l’essai randomisé contrôlé MAXIMISE

Towards a Framework for Adapting Machine Learning Components

Suchergebnisse filtern